NSC |
Compound |
Enrichment |
Correlation |
NSC 645566 |
Null |
0.0459335986102865 |
0.045022245 |
NSC 676779 |
Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop |
0.0459335986102865 |
0.19177406 |
NSC 681239 |
Bortezomib |
0.0459335986102865 |
0.17172585 |
NSC 701378 |
3-Pyridinecarbonitrile, 4-(4-chlorophenyl)- 6-[4-[[7-(trifluoromethyl)-4-quinolinyl]amino]phenyl]- 1,2-dihydro-2-oxo- |
0.0459335986102865 |
0.21557763 |
NSC 759630 |
LANATOSIDE C |
0.0459335986102865 |
-0.022408291 |
NSC 108165 |
CP 12252-1 |
0.0459335986102872 |
0.56188873 |
NSC 200692 |
Aspiculamycin hydrochloride |
0.0459335986102872 |
-0.31997108 |
NSC 637422 |
Null |
0.0459335986102872 |
-0.22549369 |
NSC 680721 |
5H-1,4,8,11-Benzotetrathiacyclotridecin- 13,14-dicarbonitrile, 2,3,6,7,9,10-hexahydro- |
0.0459335986102872 |
-0.2613032 |
NSC 682866 |
Ethanone, 1-[7-(4-chlorophenyl)-5,6-dihydro-9-methyl- 7H-benzo[h]thiazolo[2,3-b]quinazolin-10-yl]- |
0.0459335986102872 |
0.59297595 |